B12 deficiency is well-documented in long-term GLP-1 users, which is one reason why many compounded versions include B12 in the formulation
However, the FDA has determined that this evidence is limited and not conclusive
Y un estudio publicado en enero de 2025 sugiri que los medicamentos GLP-1 populares aprobados para la prdida de peso, la diabetes y las enfermedades cardacas pueden tener un potencial sin explotar para reducir los riesgos de trastornos por abuso de sustancias, psicosis, infecciones y algunos tipos de cncer y demencia
Comparison and Clinical Implications Final Verdict: Platelet-Rich Plasma is a Validated Treatment, While Peptide Therapy Requires Further Research While peptide injections show promise in preclinical studies, their role in musculoskeletal treatment remains experimental , with a lack of well-controlled human trials to confirm their efficacy
Kellys special talent for integrating information from many sources and finding practical solutions has made her a popular speaker and workshop leader
So anyway, I thought this was a very interesting study
